Jeffrey A. Bluestone
Affiliations: | University of Chicago, Chicago, IL |
Area:
Cell Biology, Immunology, Molecular BiologyGoogle:
"Jeffrey Bluestone"Children
Sign in to add trainee| Maria-Luisa Alegre | grad student | Chicago | |
| Ingrid C. Rulifson | grad student | 2000 | Chicago |
| Keshava Rajagopal | grad student | 2001 | Chicago |
| Cristina Penaranda | grad student | 2005-2010 | UCSF (Microtree) |
| Anne I Sperling | post-doc | (Neurotree) | |
| Leonardo M.R. Ferreira | post-doc | 2016- | UCSF |
| Daniel Bryan Goodman | post-doc | 2017- | UCSF (Chemistry Tree) |
| Brian T. Fife | post-doc | 2002-2007 | UCSF (Microtree) |
| Todd M. Brusko | post-doc | 2008-2011 | (Epi Tree) |
| Gaurav Chopra | post-doc | 2013-2016 | UCSF (Computational Biology Tree) |
Collaborators
Sign in to add collaborator| Eugene P Brandon | collaborator | (Neurotree) | |
| Yapeng Su | collaborator | (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lebrec H, Bui J, Clingan JM, et al. (2025) Second generation CD2-targeting LFA-3 fusion protein SBT115301 to restore immune homeostasis in autoimmune disease. Iscience. 28: 112447 |
| Stoops J, Morton T, Powell J, et al. (2025) Treg cell therapy manufacturability: current state of the art, challenges and new opportunities. Frontiers in Immunology. 16: 1604483 |
| Bluestone JA, Burnett BK, Crute CE, et al. (2025) Regulatory T cell therapies to treat autoimmune diseases and transplant rejection. Nature Immunology. 26: 819-824 |
| Muller YD, Ho P, Bluestone JA, et al. (2024) Rebalancing the Immune System to Treat Type 1 Diabetes. Cold Spring Harbor Perspectives in Medicine |
| Smith JA, Yuen BTK, Purtha W, et al. (2024) Aire mediates tolerance to insulin through thymic trimming of high-affinity T cell clones. Proceedings of the National Academy of Sciences of the United States of America. 121: e2320268121 |
| Ho P, Cahir-McFarland E, Fontenot JD, et al. (2024) Harnessing regulatory T cells to establish immune tolerance. Science Translational Medicine. 16: eadm8859 |
| Bluestone JA, McKenzie BS, Beilke J, et al. (2023) Opportunities for Treg cell therapy for the treatment of human disease. Frontiers in Immunology. 14: 1166135 |
| Goodman DB, Azimi CS, Kearns K, et al. (2022) Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies. Science Translational Medicine. 14: eabm1463 |
| VanDyke D, Iglesias M, Tomala J, et al. (2022) Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection. Cell Reports. 41: 111478 |
| Su Y, Yuan D, Chen DG, et al. (2022) Multiple early factors anticipate post-acute COVID-19 sequelae. Cell |